Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

27.8K
Overview
27.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

560
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
560
Cross-reactivity00:42

Cross-reactivity

31.3K
Overview
31.3K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

548
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
548
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

351
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
351
Antibody Structure01:10

Antibody Structure

60.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AllergenAI: a deep learning model predicting allergenicity based on protein sequence.

BMC bioinformatics·2025
Same author

Sequences and Structures of Viral Proteins Linked to the Genomes (VPg) of RNA Viruses.

Viruses·2025
Same author

Transgenerational effects of bisphenol S exposure on the development of experimental asthma.

Journal of environmental science and health. Part C, Toxicology and carcinogenesis·2025
Same author

Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE binding.

The Journal of allergy and clinical immunology·2025
Same author

Maternal exposure to bisphenol A has transgenerational effects on the development of experimental asthma through bromodomain-containing protein 4-zinc finger DHHC-type containing 1-stimulators of interferon genes axis.

International journal of environmental health research·2025
Same author

AllergenAI: a deep learning model predicting allergenicity based on protein sequence.

bioRxiv : the preprint server for biology·2024
Same journal

Key factors in the diagnosis of sesame allergy in children.

Allergy and asthma proceedings·2026
Same journal

Immunoglobulin E-mediated pumpkin seed allergy in children: Case series and narrative review with a structured literature search.

Allergy and asthma proceedings·2026
Same journal

Predictors of delayed treatment-free remission with omalizumab in chronic spontaneous urticaria.

Allergy and asthma proceedings·2026
Same journal

The digital front door: A national analysis of U.S. allergy and immunology fellowship program web sites.

Allergy and asthma proceedings·2026
Same journal

The impact of dietary patterns on the risk of asthma in children.

Allergy and asthma proceedings·2026
Same journal

The alpha-gal syndrome: Understanding the role of tick bites, and the delays in severe anaphylaxis.

Allergy and asthma proceedings·2026
See all related articles

Related Experiment Video

Updated: Jul 22, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.4K

Peptide immunotherapy for aeroallergens.

Terumi Midoro-Horiuti1, Catherine H Schein2

  • 1From the Department of Pediatrics, Clinical and Experimental Immunology and Infectious Diseases, University of Texas Medical Branch, Texas, Galveston.

Allergy and Asthma Proceedings
|July 22, 2023
PubMed
Summary
This summary is machine-generated.

Peptide immunotherapy for inhaled allergens shows promise but faces challenges. New hypoallergenic peptides and computational methods may lead to more effective treatments by targeting B cell epitopes.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.3K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.3K

Related Experiment Videos

Last Updated: Jul 22, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies
10:31

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

12.4K
Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

23.3K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.3K

Area of Science:

  • Allergy and Immunology
  • Immunotherapy Research
  • Computational Biology

Background:

  • Allergen-specific immunotherapy (SIT) has been used for over 100 years to treat allergies.
  • Ongoing research aims to enhance SIT efficacy and minimize adverse effects.
  • Understanding the mechanisms of SIT, including T-cell regulation and antibody class switching, is crucial.

Purpose of the Study:

  • To review the existing literature on peptide immunotherapy for inhaled allergens.
  • To evaluate the potential of T-cell epitope peptides in SIT.
  • To explore novel approaches for developing effective peptide-based immunotherapies.

Main Methods:

  • A comprehensive literature search was conducted on Medline for studies on peptide SIT for aeroallergens.
  • Analysis of existing research on allergen modification and treatment routes.
  • Review of cellular, animal, and clinical study outcomes.

Main Results:

  • T-cell epitope peptides, lacking IgE-binding sites, were initially promising for inducing regulatory T (Treg) cells and reducing T helper (Th)2 cells.
  • While cellular and animal studies showed success, clinical trials of T-cell peptide immunotherapy yielded limited efficacy and side effects.
  • Challenges included high placebo response rates and the development of IgE against T-cell epitopes.

Conclusions:

  • Hypoallergenic B cell epitope peptides represent a promising new direction for peptide immunotherapy.
  • Computational identification methods are vital for discovering and designing novel peptide immunotherapies.
  • Future strategies may involve modifying IgE-allergen binding through blocking antibodies.